Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A R Blight

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
Carcinogenesis|June 1, 1987
Failure of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) to inhibit cell-cell coupling in newborn mouse epidermal cells and Chinese hamster V79 cells under non-standard culture conditionsD R Miller, L Istone, W Burkart, et al.
Paraplegia|November 1, 1993
Effects of induced hypothermia on somatosensory evoked potentials in patients with chronic spinal cord injuryK C Hayes, J T Hsieh, P J Potter, et al.
Journal of Neurotrauma|August 1, 1994
4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injuryK C Hayes, P J Potter, D L Wolfe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging studyA D Goodman, J A Cohen, A Cross, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Effects of applied electric fields on clinical cases of complete paraplegia in dogsR B Borgens, J P Toombs, A R Blight, et al.
Spinal Cord|June 15, 2006
Phase 2 trial of sustained-release fampridine in chronic spinal cord injuryD D Cardenas, J Ditunno, V Graziani, et al.
Journal of Clinical Pharmacology|May 2, 2003
Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injuryK C Hayes, M A Katz, J G Devane, et al.
Paraplegia|April 1, 1993
Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injuryK C Hayes, A R Blight, P J Potter, et al.
Neurology|August 2, 2008
Dose comparison trial of sustained-release fampridine in multiple sclerosisA D Goodman, T R Brown, J A Cohen, et al.
Spinal Cord|November 13, 2013
Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injuryD D Cardenas, J F Ditunno, V Graziani, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
Carcinogenesis|June 1, 1987
Failure of the tumor promoter 12-O-tetradecanoylphorbol-13-acetate (TPA) to inhibit cell-cell coupling in newborn mouse epidermal cells and Chinese hamster V79 cells under non-standard culture conditionsD R Miller, L Istone, W Burkart, et al.
Paraplegia|November 1, 1993
Effects of induced hypothermia on somatosensory evoked potentials in patients with chronic spinal cord injuryK C Hayes, J T Hsieh, P J Potter, et al.
Journal of Neurotrauma|August 1, 1994
4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injuryK C Hayes, P J Potter, D L Wolfe, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 19, 2007
Fampridine-SR in multiple sclerosis: a randomized, double-blind, placebo-controlled, dose-ranging studyA D Goodman, J A Cohen, A Cross, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Effects of applied electric fields on clinical cases of complete paraplegia in dogsR B Borgens, J P Toombs, A R Blight, et al.
Spinal Cord|June 15, 2006
Phase 2 trial of sustained-release fampridine in chronic spinal cord injuryD D Cardenas, J Ditunno, V Graziani, et al.
Journal of Clinical Pharmacology|May 2, 2003
Pharmacokinetics of an immediate-release oral formulation of Fampridine (4-aminopyridine) in normal subjects and patients with spinal cord injuryK C Hayes, M A Katz, J G Devane, et al.
Paraplegia|April 1, 1993
Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injuryK C Hayes, A R Blight, P J Potter, et al.
Neurology|August 2, 2008
Dose comparison trial of sustained-release fampridine in multiple sclerosisA D Goodman, T R Brown, J A Cohen, et al.
Spinal Cord|November 13, 2013
Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injuryD D Cardenas, J F Ditunno, V Graziani, et al.
Pageof 8